Avandia
Product Images NDC 54868-4198

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Avandia (NDC 54868-4198). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Package Label For 2 mg (Avandia 2mg Package Label)

Image Of Package Label For 2 mg (Avandia 2mg Package Label)
Avandia 2 mg tablets packaging label from Physicians Total Care, Inc. The label states the active ingredient rosiglitazone maleate, with a package count of 30 tablets. It includes cautionary information indicating federal law restricts dispensing without prescription, along with lot, expiration, and storage instructions.*
FDA Label Image

Image Of Package Label For 4 mg (Avandia 4mg Package Label)

Image Of Package Label For 4 mg (Avandia 4mg Package Label)
Avandia 4 mg tablets packaging label from Physicians Total Care, Inc. Contains rosiglitazone maleate. The label shows a 60 tablet count, with warnings about federal restrictions on sale without a prescription and storage instructions. The lot number and expiration date details are partially visible.*
FDA Label Image

Image Of Package Label For 8 mg (Avandia 8mg Package Label)

Image Of Package Label For 8 mg (Avandia 8mg Package Label)
Packaging label for Avandia 8MG manufactured by Glaxo Smith Kline and distributed by Physicians Total Care, Inc. It includes lot number 000, expiration date 01/60, and features a barcode with NDC 54860-4221-0.*
FDA Label Image

Image Of Figure 1. Forest Plot Of Odds Ratios (Figure 1.forest Plot Of Odds Ratios)

Image Of Figure 1. Forest Plot Of Odds Ratios (Figure 1.forest Plot Of Odds Ratios)
A forest plot chart titled 'Myocardial Ischemic Adverse Events' comparing incidences between rosiglitazone (RSG) and control groups across Active Controlled, Placebo Controlled, Add-on to Insulin, and Overall categories. The chart presents data points with confidence intervals indicating relative risk ratios favoring either RSG or control.*
FDA Label Image

Image Of Figure 2 Hazard Ratios (Figure 2.hazard Ratios)

Image Of Figure 2 Hazard Ratios (Figure 2.hazard Ratios)
A forest plot from clinical studies showing comparative outcomes of rosiglitazone (RSG) versus controls for three endpoints: Major Adverse Cardiovascular Events (MACE), Myocardial Infarction, and Total Mortality. The plot presents hazard ratios with confidence intervals across several studies (RECORD, ADOPT, DREAM) and totals, indicating effects favoring RSG or control groups.*
FDA Label Image

Image Of Figure 3 (Figure 3)

Image Of Figure 3 (Figure 3)
A line graph comparing mean HbA1c percentage over time (weeks) between Metformin and Rosiglitazone groups. The x-axis represents time in weeks from screening to 24 weeks, and the y-axis shows mean HbA1c percentage from 7.0 to 9.0%. Data points include error bars representing standard error (SE).*
FDA Label Image

Image Of Figure 4 (Figure 4)

Image Of Figure 4 (Figure 4)
A line graph comparing mean fasting plasma glucose (FPG) levels over 52 weeks of treatment with Glyburide, Avandia 2 mg twice daily, and Avandia 4 mg twice daily. The x-axis shows treatment weeks, and the y-axis shows mean FPG in mg/dL. The graph includes error bars representing standard error (SE).*
FDA Label Image

Image Of Figure 5 (Figure 5)

Image Of Figure 5 (Figure 5)
A line graph showing the mean HbA1c percentage over treatment weeks for patients treated with Glyburide, Avandia 2 mg twice daily, and Avandia 4 mg twice daily. The graph includes error bars representing the standard error over a period of 0 to 52 weeks.*
FDA Label Image

Image Of Chemical Structure (Chemical Structure)

Image Of Chemical Structure (Chemical Structure)
Chemical structure diagram showing the molecular structure of the active ingredient in Avandia by Physicians Total Care, Inc. The image depicts a complex organic molecule including a pyridine ring, a thiophene ring, and a carboxylic acid functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.